J Gumà Selected Research

Drug Therapy (Chemotherapy)

1/2021	Patterns of relapse and treatment outcome after active surveillance or adjuvant carboplatin for stage I seminoma: a retrospective study of the Spanish Germ Cell Cancer Group.
11/2014	Prognostic factors for relapse in stage I seminoma: a new nomogram derived from three consecutive, risk-adapted studies from the Spanish Germ Cell Cancer Group (SGCCG).
12/2002	Clinical pattern and therapeutic results achieved in 1490 patients with germ-cell tumours of the testis: the experience of the Spanish Germ-Cell Cancer Group (GG).
4/2001	[Clinical pattern and therapeutic results obtained in Germ-Cell testicular cancer in Spain based on a consecutive series of 1250 patients].
4/2001	E400P in advanced seminoma of good prognosis according to the international germ cell cancer collaborative group (IGCCCG) classification: the Spanish Germ Cell Cancer Group experience.
4/2001	Secondary prophylactic G-CSF (filgrastim) administration in chemotherapy of stage I and II Hodgkin's lymphoma with ABVD.
12/2000	[Oncologic treatment of oto-neuro-ophthalmological metastases and their complications].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

J Gumà Research Topics

Disease

6	Seminoma 01/2021 - 04/2001
5	Neoplasms (Cancer) 10/2019 - 12/2000
2	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 01/2021 - 12/2002
1	Nonseminomatous germ cell tumor 10/2019
1	Testicular Neoplasms (Testicular Cancer) 10/2019
1	Embryonal Carcinoma 10/2019
1	Pleural Effusion (Pleural Effusions) 01/2016
1	Pneumonia (Pneumonitis) 01/2016
1	Acute-Phase Reaction 01/2016
1	Hodgkin Disease (Hodgkin's Disease) 04/2001
1	Febrile Neutropenia 04/2001
1	Neutropenia 04/2001
1	Neoplasm Metastasis (Metastasis) 12/2000
1	Iatrogenic Disease 12/2000

Drug/Important Bio-Agent (IBA)

3	Carboplatin (JM8)FDA LinkGeneric 01/2021 - 06/2003
2	Cisplatin (Platino)FDA LinkGeneric 01/2021 - 12/2002
1	Fetal Proteins (Fetoprotein)IBA 10/2019
1	Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric 10/2019
1	Tumor Biomarkers (Tumor Markers)IBA 10/2019
1	AdipokinesIBA 01/2018
1	LipidsIBA 01/2018
1	HDL CholesterolIBA 01/2016
1	Biomarkers (Surrogate Marker)IBA 01/2016
1	Etoposide (VP 16)FDA LinkGeneric 12/2002
1	Dacarbazine (DIC)FDA LinkGeneric 04/2001
1	Filgrastim (Neupogen)FDA Link 04/2001
1	Bleomycin (Blenoxane)FDA LinkGeneric 04/2001
1	Vinblastine (Vinblastine Sulfate)FDA Link 04/2001
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 04/2001
1	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2001
1	Hormones (Hormone)IBA 12/2000

Therapy/Procedure

7	Drug Therapy (Chemotherapy) 01/2021 - 12/2000
3	Adjuvant Chemotherapy 01/2021 - 06/2003
3	Radiotherapy 11/2014 - 12/2000
2	Orchiectomy (Orchidectomy) 10/2019 - 12/2002
2	Therapeutics 10/2019 - 06/2003
1	Treatment Delay 04/2001